Related Experiment Video
Updated: Aug 7, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
BRD2 is one of BRD7-interacting proteins and its over-expression could initiate apoptosis
Ming Zhou1, Xiao-Jie Xu, Hou-De Zhou
1Cancer Research Institute, Central South University Xiang-Ya School of Medicine, Changsha, Hunan, 410078, China.
Abstract:
BRD7 is a potential nuclear transcription regulation factor related to nasopharyngeal carcinoma (NPC). BRD2, a putative BRD7-interacting protein, has been screened from human fetal brain cDNA library by yeast two-hybrid system. This study was to further identify the interaction between BRD7 and BRD2 in mammalian cells, and to investigate the subcellular localization of BRD2, as well as the effect on the functions of cell biology. Both immunoprecipitation and subcellular colocalization were performed together to identify the interaction of BRD7 with full-length BRD2, as well as C-terminal truncated BRD2 or N-terminal truncated BRD2. GFP direct fluorescence and Hochest 33258 staining were used to investigate the cellular localization pattern of BRD2 and the roles in initiating cell apoptosis in COS7 and HNE1. The results showed that BRD7 could interact with BRD2 and the region from amino acid 430 to 798 of BRD2 was critical for the interaction of BRD2 with BRD7. BRD2 mainly localizes in nucleus in two distribution patterns, diffused and dotted, and BRD2 has distinct roles in initiating apoptosis, and the dotted distribution pattern of BRD2 in nucleus may be a morphologic marker of cell apoptosis.
Insights
Bromodomain-containing protein 7 (BRD7) interacts with BRD2, a protein implicated in nasopharyngeal carcinoma (NPC). BRD2 localizes to the nucleus and plays a role in initiating cell apoptosis, with a specific nuclear pattern potentially marking this process.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Bromodomain-containing protein 7 (BRD7) is a potential nuclear transcription regulator linked to nasopharyngeal carcinoma (NPC).
- BRD2, a potential binding partner of BRD7, was previously identified via a yeast two-hybrid screen.
- Understanding the interaction between BRD7 and BRD2 is crucial for elucidating their roles in cellular functions and NPC pathogenesis.
Purpose of the Study:
- To confirm the interaction between BRD7 and BRD2 in mammalian cells.
- To investigate the subcellular localization of BRD2.
- To determine the role of BRD2 in cell biology, particularly in initiating apoptosis.
Main Methods:
- Immunoprecipitation assays to verify BRD7-BRD2 interaction, including truncated BRD2 constructs.
- Subcellular colocalization studies to assess the spatial relationship between BRD7 and BRD2.
- GFP fluorescence and Hoechst 33258 staining to analyze BRD2 localization and its effect on apoptosis in COS7 and HNE1 cells.
Main Results:
- BRD7 directly interacts with BRD2 in mammalian cells.
- The interaction interface is mapped to amino acids 430–798 of BRD2.
- BRD2 exhibits nuclear localization with both diffused and dotted patterns, and the dotted pattern correlates with the initiation of apoptosis.
Conclusions:
- BRD7 and BRD2 form a complex, with a specific region of BRD2 mediating the interaction.
- BRD2's nuclear localization, particularly its dotted pattern, is associated with the induction of apoptosis.
- These findings provide insights into the molecular mechanisms underlying BRD2 function and its potential role in NPC.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Abnormal Proliferation
Caspases
Apoptosis
The Extrinsic Apoptotic Pathway
